3-(hydroxy)propyl-[2-amino-2-[1-(4-fluorophenyl)-2-methyl-5-(4-methylsulphonyl phenyl)-1H-pyrrol-3-yl]]-acetate | 1363374-91-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡咯
• 英文名称: 3-(hydroxy)propyl-[2-amino-2-[1-(4-fluorophenyl)-2-methyl-5-(4-methylsulphonyl phenyl)-1H-pyrrol-3-yl]]-acetate
• 英文别名: (R,S)-3-(hydroxy)propyl [2-amino-2-[1-(4-fluorophenyl)-2-methyl-5-(4-methylsulphonylphenyl)-1H-pyrrol-3-yl]]acetate.；3-Hydroxypropyl 2-amino-2-[1-(4-fluorophenyl)-2-methyl-5-(4-methylsulfonylphenyl)pyrrol-3-yl]acetate；3-hydroxypropyl 2-amino-2-[1-(4-fluorophenyl)-2-methyl-5-(4-methylsulfonylphenyl)pyrrol-3-yl]acetate
• CAS: 1363374-91-7
• 化学式: C₂₃H₂₅FN₂O₅S
• 分子量: 460.526
• InChiKey: GCBUIHJFEOFNFQ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.4
• 重原子数：
  32
• 可旋转键数：
  9
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.26
• 拓扑面积：
  120
• 氢给体数：
  2
• 氢受体数：
  7

反应信息

• 作为产物：
  描述：

  1-[4-(methylsulfonyl)phenyl]pentane-1,4-dione 在 4-二甲氨基吡啶 、 甲酸 、 palladium on activated charcoal 、 盐酸羟胺 、 水 、 甲酸铵 、 sodium acetate 、 四氯化钛 、 sodium carbonate 、 对甲苯磺酸 、 盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺 、 sodium hydroxide 、 锌 作用下， 以 1,4-二氧六环 、 甲醇 、 乙醇 、 二氯甲烷 、 异丙醇 为溶剂， 160.0 ℃ 、1.17 MPa 条件下， 反应 68.83h， 生成 3-(hydroxy)propyl-[2-amino-2-[1-(4-fluorophenyl)-2-methyl-5-(4-methylsulphonyl phenyl)-1H-pyrrol-3-yl]]-acetate
  参考文献：
  名称：

  Improving the solubility of a new class of antiinflammatory pharmacodynamic hybrids, that release nitric oxide and inhibit cycloxygenase-2 isoenzyme

  摘要：

  The development of a novel class of pharmacodynamic hybrids that inhibits COX-2 isoform is reported. These molecules display enhanced nitric oxide releasing properties due to the presence of an ionisable moiety. The in vivo analgesic/anti-inflammatory activity was maintained in relation to the parent compounds. (c) 2012 Elsevier Masson SAS. All rights reserved.

  DOI：

  10.1016/j.ejmech.2012.10.014

文献信息

• 1,5-Diaryl-2-alkylpyrrole-3-Substituted Nitro Esters, Selective COX-2 Inhibitors and Nitric Oxide Donors
  申请人：Giordani Antonio

  公开号：US20130165494A1

  公开（公告）日：2013-06-27

  1,5-diaryl-2-alkylpyrrole-3-substituted nitro esters, of Formula (I) are provided. Such compounds are potent and selective COX-2 inhibitors which are able to release NO in concentrations that make it possible to counteract the side effects due to selective COX-2 inhibition, without giving rise to hypotensive effects. Formula (I) includes compounds wherein the groups R′ and R″ are: —H, —F, —Cl, —Br, —CH 3 , —CF 3 , —OCH 3 , —SCH 3 , R1 is methyl, ethyl, trifluoromethyl, hydroxymethyl, methoxymethyl and the substituent in position −3 of the pyrrole ring is a chain, where the groups X, Y, Z, W and R2 are: X is a carbonyl or a group —(CHR 3 )—, Y is an oxygen atom or the group —NR 3 — and Z is a carbonyl or a group —(CHR 3 )—, or a [—CH(COOH)—] group, or a group —(NR 3 )—, W is an aliphatic chain substituted with one or two (—O—NO 2 ) groups, R2 is: —H, —OH, —OCH 3 , or —NHR 3 . R 3 is: —H, —CH 3 , —CH 2 CH 3 , [—CH 2 (CH 3 ) 2 ]. R′″ is methylsulphonyl or sulphonamido. Pharmaceutical formulations and methods of making an using such formulations are also provided.

  提供的是1,5-二芳基-2-烷基吡咯-3-取代硝基酯，其分子式为(I)。这类化合物是强效且选择性的COX-2抑制剂，能够以在浓度上足以抵消由于选择性COX-2抑制引起的副作用的NO释放，而不会引起低血压效应。公式(I)包括的化合物中，基团R'和R"为：—H，—F，—Cl，—Br，—CH3，—CF3，—OCH3，—SCH3，R1为甲基，乙基，三氟甲基，羟甲基，甲氧甲基，且吡咯环上-3位的取代基为链状，其中X、Y、Z、W和R2分别为：X为羰基或—(CHR3)—基团，Y为氧原子或—NR3—基团，Z为羰基或—(CHR3)—基团，或[—CH(COOH)—]基团，或—(NR3)—基团，W为用一或两个(—O—NO2)基团取代的脂肪链，R2为：—H，—OH，—OCH3，或—NHR3。R3为：—H，—CH3，—CH2CH3，[—CH2(CH3)2]。R′″为甲基磺酰基或磺酰胺基。还提供了用于制备和使用此类化合物的药物配方和方法。
• US9162979B2
  申请人：——

  公开号：US9162979B2

  公开（公告）日：2015-10-20
• Improving the solubility of a new class of antiinflammatory pharmacodynamic hybrids, that release nitric oxide and inhibit cycloxygenase-2 isoenzyme
  作者：Mariangela Biava、Claudio Battilocchio、Giovanna Poce、Salvatore Alfonso、Sara Consalvi、Giulio Cesare Porretta、Silvia Schenone、Vincenzo Calderone、Alma Martelli、Lara Testai、Carla Ghelardini、Lorenzo Di Cesare Mannelli、Lidia Sautebin、Antonietta Rossi、Antonio Giordani、Paola Patrignani、Maurizio Anzini

  DOI：10.1016/j.ejmech.2012.10.014

  日期：2012.12

  The development of a novel class of pharmacodynamic hybrids that inhibits COX-2 isoform is reported. These molecules display enhanced nitric oxide releasing properties due to the presence of an ionisable moiety. The in vivo analgesic/anti-inflammatory activity was maintained in relation to the parent compounds. (c) 2012 Elsevier Masson SAS. All rights reserved.